Artelo Biosciences, Inc.
PublicArtelo Biosciences, Inc. is now publicly traded
The data on this page reflects Artelo Biosciences, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Seed Round
Mar 20, 2026
Total Funding Raised
$18.14M
Company Overview
Artelo Biosciences, Inc. has raised $18.14M. It was founded in 2011.
Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics targeting lipid-signaling pathways to treat cancer, pain, and other conditions.
AI Layer
Non-AI
Artelo Biosciences, Inc. Comparables
Compare Artelo Biosciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tensegrity Pharma, Inc. | 63% | |
| Pannex Therapeutics | 60% | |
| Andira Pharmaceuticals | 59% |
For institutional investors. Book with your work email.
Artelo Biosciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 20, 2026 | ||||
| Seed Round | Mar 12, 2026 | ||||
| Seed Round | Mar 12, 2026 | ||||
| Private Placement | Aug 5, 2025 | ||||
| Private Placement | Jun 26, 2025 | ||||
Private Placement | May 13, 2022 |
For institutional investors. Book with your work email.
Artelo Biosciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.